Cardinal Health raises 2025 profit outlook after strong first-quarter earnings

Cardinal Health Inc. reported a first-quarter 2025 adjusted earnings per share of $1.88, a 9% increase from last year, surpassing expectations. Sales fell 4% to $52.28 billion, but still exceeded forecasts. The Pharmaceutical and Specialty Solutions segment saw a 5% revenue decline to $48.0 billion. However, excluding a contract expiration, revenue rose 16%, driven by strong sales of brand and specialty pharmaceuticals. Cardinal Health raised its fiscal 2025 profit outlook for adjusted EPS to $7.75-$7.90, up from $7.55-$7.70. The company also adjusted its profit expectations for its Global Medical Products and Distribution segment due to rising costs.